Baird Financial Group’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
WAM
AC
VF
HF
TRCT
HI
FDCDDQ
APC
Baird Financial Group's VTAK Position: Q3 2024 in Review
Baird Financial Group sold out of Catheter Precision (VTAK) in Q3 2024, closing a stake of 529 shares — an estimated $58.8K sold.
Baird Financial Group first reported a position in VTAK in Q2 2023 and held it in 5 quarters. The position peaked at $92.5K in Q2 2023. 9 funds tracked by Wall St. Rank hold VTAK as of Q3 2024.
- Baird Financial Group reported no remaining Catheter Precision position as of Q3 2024 after selling out during the quarter.
- Baird Financial Group sold 529 Catheter Precision shares in Q3 2024, an estimated $58.8K.
- Baird Financial Group first reported a position in Catheter Precision in Q2 2023 and held it in 5 quarters.
- Baird Financial Group's Catheter Precision position peaked at $92.5K in Q2 2023.
- 9 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2024.
Based on Baird Financial Group's 13F filing for Q3 2024, filed 14 Nov 2024.